As of 2024-09-17, the Intrinsic Value of IRadimed Corp (IRMD) is
59.12 USD. This IRMD valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 49.06 USD, the upside of IRadimed Corp is
%.
The range of the Intrinsic Value is 39.61 - 134.79 USD
59.12 USD
Intrinsic Value
IRMD Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
39.61 - 134.79 |
59.12 |
20.5% |
| DCF (Growth 10y) |
56.62 - 190.00 |
84.09 |
71.4% |
| DCF (EBITDA 5y) |
64.20 - 72.79 |
69.09 |
40.8% |
| DCF (EBITDA 10y) |
81.02 - 98.33 |
90.06 |
83.6% |
| Fair Value |
36.79 - 36.79 |
36.79 |
-25.00% |
| P/E |
50.09 - 64.20 |
55.88 |
13.9% |
| EV/EBITDA |
45.61 - 50.09 |
48.65 |
-0.8% |
| EPV |
14.16 - 17.21 |
15.69 |
-68.0% |
| DDM - Stable |
10.87 - 38.52 |
24.70 |
-49.7% |
| DDM - Multi |
20.95 - 55.86 |
30.27 |
-38.3% |
IRMD Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
621.59 |
| Beta |
0.65 |
| Outstanding shares (mil) |
12.67 |
| Enterprise Value (mil) |
573.06 |
| Market risk premium |
4.60% |
| Cost of Equity |
10.46% |
| Cost of Debt |
5.00% |
| WACC |
7.28% |